Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

NCT04902105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: ecopipam HCL
DRUG: Mefenamic acid
DRUG: Divalproex Sodium ER

Sponsor

Emalex Biosciences Inc.

Collaborators

[object Object]
[object Object]